Search Results - "Schreuder, H W B"

Refine Results
  1. 1

    The route to diagnosis of sarcoma patients: Results from an interview study in the Netherlands and the United Kingdom by Soomers, Vicky L M N, van der Graaf, Winette T A, Zaidi, Shane, Kaal, Suzanne E J, Hayes, Andrew J, Schreuder, Bart H W B, Jones, Robin L, Desar, Ingrid M E, Husson, Olga

    Published in PloS one (07-12-2020)
    “…Sarcomas are rare tumours. Early diagnosis is challenging, but important for local control and potentially survival and quality of life(QoL). We investigated…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Prognostic and therapeutic relevance of the IGF pathway in Ewing’s sarcoma patients by van de Luijtgaarden, A. C. M., Versleijen-Jonkers, Y. M. H., Roeffen, M. H. S., Schreuder, H. W. B., Flucke, U. E., van der Graaf, W. T. A.

    Published in Targeted oncology (01-12-2013)
    “…The optimal target and timing of drugs interfering with the insulin-like growth factor (IGF) signaling system in Ewing’s sarcoma (ES) remain undetermined. We…”
    Get full text
    Journal Article
  5. 5

    Hemicortical Resection and Inlay Allograft Reconstruction for Primary Bone Tumors: A Retrospective Evaluation in the Netherlands and Review of the Literature by Bus, M.P.A, Bramer, J.A.M, Schaap, G.R, Schreuder, H.W.B, Jutte, P.C, van der Geest, I.C.M, van de Sande, M.A.J, Dijkstra, P.D.S

    “…BACKGROUND:Selected primary tumors of the long bones can be adequately treated with hemicortical resection, allowing for optimal function without compromising…”
    Get full text
    Journal Article
  6. 6

    Cryosurgery as Additional Treatment in Tenosynovial Giant Cell Tumors by Verspoor, F. G. M., Scholte, A., van der Geest, I. C. M., Hannink, G., Schreuder, H. W. B.

    Published in Sarcoma (2016)
    “…Introduction. Tenosynovial giant cell tumors (TGCT) emerge from the synovium and can behave aggressively. Surgical resection is the standard treatment…”
    Get full text
    Journal Article
  7. 7

    The saddle prosthesis in pelvic primary and secondary musculoskeletal tumors : functional results at several postoperative intervals by RENARD, A. J. S, VETH, R. P. H, SCHREUDER, H. W. B, PRUSZCZYNSKI, M, KELLER, A, VAN HOESEL, Q, BÖKKERINK, J. P. M

    “…The first purpose of this study was to evaluate the saddle prosthesis in patients with periacetabular tumors in terms of the functional results obtained after…”
    Get full text
    Journal Article
  8. 8

    Hardware Failure: A Potential Pitfall in Assessing Recurrent Ewingʼs Sarcoma on Bone Scintigraphy by Vriens, Dennis, Arens, Anne I. J, de Rooy, Jacky W. J, Schreuder, Bart (H.) W. B, Brons, Paul P. T, Gotthardt, Martin

    Published in Clinical nuclear medicine (01-06-2010)
    “…A 14-year-old boy was treated for nonmetastasized femoral Ewing sarcoma with inductive and consolidation chemotherapy with surgical resection of the diaphysis…”
    Get full text
    Journal Article
  9. 9

    The effect of surgery in tenosynovial giant cell tumours as measured by patient-reported outcomes on quality of life and joint function by Verspoor, F G M, Mastboom, M J L, Hannink, G, W T A van der Graaf, M A J van de Sande, Schreuder, H W B

    “…AimsThe aim of this study was to evaluate health-related quality of life (HRQoL) and joint function in tenosynovial giant cell tumour (TGCT) patients before…”
    Get full text
    Journal Article
  10. 10

    Treatments of tenosynovial giant cell tumours of the temperomandibular joint: a report of three cases and a review of literature by Verspoor, F.G.M., Mastboom, M.J.L., Weijs, W.L.J., Koetsveld, A.C., Schreuder, H.W.B., Flucke, U.

    “…Tenosynovial giant cell tumours (TGCTs) are benign lesions affecting synovial joints. The classified subtypes are localized and diffuse. They seldom occur in…”
    Get full text
    Journal Article
  11. 11

    Severity classification of Tenosynovial Giant Cell Tumours on MR imaging by Mastboom, M.J.L., Verspoor, F.G.M., Hanff, D.F., Gademan, M.G.J., Dijkstra, P.D.S., Schreuder, H.W.B., Bloem, J.L., van der Wal, R.J.P., van de Sande, M.A.J.

    Published in Surgical oncology (01-09-2018)
    “…Current development of novel systemic agents requires identification and monitoring of extensive Tenosynovial Giant Cell Tumours (TGCT). This study defines…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Bone cysts in patients with afibrinogenaemia: a literature review and two new cases by van Meegeren, M. E. R., de Rooy, J. W. J., Schreuder, H. W. B., Brons, P. P. T.

    “…Summary Afibrinogenaemia is an autosomal recessive disease with an estimated prevalence of approximately one in a million. The most common symptoms of…”
    Get full text
    Journal Article
  14. 14

    Aneurysmal bone cyst: The role of cryosurgery as local adjuvant treatment by Peeters, S.P., Van der Geest, I.C.M., de Rooy, J.W.J., Veth, R.P.H., Schreuder, H.W.B.

    Published in Journal of surgical oncology (15-12-2009)
    “…Background Aneurysmal bone cysts (ABCs) are most often treated with intralesional surgery (curettage) and additional bone grafting. There is debate on whether…”
    Get full text
    Journal Article
  15. 15

    Bone grafting of cryosurgically treated bone defects: experiments in goats by Keijser, L C M, Schreuder, H W B, Boons, H W, Keulers, B J, Buma, P, Huiskes, R, Veth, R P H

    Published in Clinical orthopaedics and related research (01-03-2002)
    “…It is hypothesized that cryosurgically treated bone defects are inappropriate host sites for cancellous bone grafting. The influence of autologous cancellous…”
    Get more information
    Journal Article
  16. 16
  17. 17

    Oncological and functional results of cryosurgical therapy of enchondromas and chondrosarcomas grade 1 by van der Geest, I.C.M., de Valk, M.H., de Rooy, J.W.J., Pruszczynski, M., Veth, R.P.H., Schreuder, H.W.B.

    Published in Journal of surgical oncology (01-11-2008)
    “…Background and Objectives Cryosurgery using liquid nitrogen is used as adjuvant treatment after intralesional resection of bone tumours to induce cell death…”
    Get full text
    Journal Article
  18. 18

    Survival of massive allografts in segmental oncological bone defect reconstructions by Bullens, P. H. J., Minderhoud, N. M., de Waal Malefijt, M. C., Veth, R. P. H., Buma, P., Schreuder, H. W. B.

    Published in International orthopaedics (01-06-2009)
    “…Reconstructions of large segmental bone defects after resection of bone tumours with massive structural allografts have a high number of reported complications…”
    Get full text
    Journal Article
  19. 19

    High prevalence of late adverse events in malignant bone tumour survivors diagnosed at adult age by van de Luijtgaarden, A C M, Kapusta, L, Bellersen, L, Bokkerink, J P M, Kaal, S E J, Versleijen-Jonkers, Y M H, Schreuder, H W B, van der Graaf, W T A

    Published in Netherlands journal of medicine (01-12-2014)
    “…Late treatment-related adverse events are particularly prevalent in survivors of childhood bone cancer because of the combination of cytotoxic drugs, major…”
    Get full text
    Journal Article
  20. 20

    Cryosurgery in long bones; an experimental study of necrosis and revitalization in rabbits by KEIJSER, L. C. M, SCHREUDER, H. W. B, BUMA, P, WEINANS, H, VETH, R. P. H

    Published in Archives of orthopaedic and trauma surgery (01-11-1999)
    “…Cryosurgery is an established adjuvant treatment of bone tumors which reduces the local recurrence rate. In this study, cryosurgical experiments were carried…”
    Get full text
    Journal Article